Medical Education Division
Our Products
On-Line Store

Google
 
Web www.brooksidepress.org

Operational Medicine 2001
Vitamin K (Phytonadione, Mephyton, AquaMephyton)

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

 
 

Category:

  • Vitamin

Description:

  • Dietary supplement; fat-soluble vitamin

Indications:

  • Vitamin K deficiency

  • Coagulation disorders (blood clotting factors)

  • Anticoagulant-induced prothrombin deficiency

  • Prophylaxis and treatment of hemorrhagic disease in newborn

  • Warfarin overdose antidote

Contraindications:

  • Avoid intravenous administration unless unavoidable.  Administer SQ or IM, if IV must be used give very slowly, not exceeding 1mg per minute.

Precautions:

  • Pregnancy category C

  • Vitamin K deficiency is

  • Patients may develop hypervitaminosis K with excessive intravenous dosages.  Symptoms of hypervitaminosis are “flushing sensations”, taste changes and rarely, dizziness sweating and rapid and weak pulse.

  • Vitamin K will NOT reverse the anticoagulant effects of heparin.

  • Reversal of coumarin class (warfarin) anticoagulation takes from 1-2 hours.

  • Vitamin K is excreted into breast milk.

Adverse Reactions (Side Effects):

Relatively non-toxic in therapeutic doses

Hyperbilirubinemia in newborns, occurring at doses greater than recommended.  

Dosage:

  • Dietary sources: pork, liver, green leafy vegetables (spinach, broccoli), GI flora can produce from diet

  • Administered in oral soft gelatin capsules or injection

  • Dietary supplementation (RDA: recommended daily allowance):

    • Infants: 10-20mcg

    • Children: 15-100mcg

    • Adult males: 45-80 mcg per day

    • Adults females: 45-65 mcg per day

  • Anticoagulant-induced prothrombin deficiency: 2.5-10mg per day (up to 25mg initially)

  • Hemorrhagic disease in newborn:

    • prophylaxis: single IM dose 0.5-1mg within 1 hour of birth, may repeat in 2-3 weeks.  Mother may receive 1-5mg 12-24 hours before delivery.  Oral doses of 2mg are adequate.

    • treatment: 1mg SQ or IM, in conjunction with proper laboratory testing of PT.

  • Hypoprothrombinemia in adults:

    • 2.5-25mg.  Amount and route of administration depends on severity of disease.

 

 


Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001

Health Care in Military Settings

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products